candesartan has been researched along with Glaucoma in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the neuroprotective effect of candesartan, an angiotensin II type 1 receptor (AT1-R) blocker, against the neurotoxicity of the retinal ganglion cells (RGCs) in an animal model of glaucoma." | 3.75 | Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma. ( Fukuda, K; Hirooka, K; Shiraga, F; Yang, H, 2009) |
| " The angioedema regressed after withdrawal of candesartan, an angiotensin II antagonist that the patient had taken for 1 year." | 3.72 | Malignant glaucoma due to drug-related angioedema. ( Hille, A; Hille, K; Ruprecht, KW, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, H | 1 |
| Hirooka, K | 1 |
| Fukuda, K | 1 |
| Shiraga, F | 1 |
| Hille, K | 1 |
| Hille, A | 1 |
| Ruprecht, KW | 1 |
2 other studies available for candesartan and Glaucoma
| Article | Year |
|---|---|
Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl | 2009 |
Malignant glaucoma due to drug-related angioedema.
Topics: Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Comp | 2003 |